SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUERRINI, Remo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.783
AS - Asia 12.733
EU - Europa 8.573
SA - Sud America 2.077
AF - Africa 199
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 54.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.285
SG - Singapore 5.324
CN - Cina 3.674
DE - Germania 1.818
BR - Brasile 1.721
UA - Ucraina 1.688
IT - Italia 1.434
HK - Hong Kong 1.292
GB - Regno Unito 1.018
TR - Turchia 919
VN - Vietnam 700
FI - Finlandia 667
SE - Svezia 460
RU - Federazione Russa 402
PL - Polonia 348
CA - Canada 253
FR - Francia 207
MX - Messico 201
IN - India 146
ID - Indonesia 135
AR - Argentina 130
JP - Giappone 122
BE - Belgio 103
ZA - Sudafrica 98
BD - Bangladesh 96
NL - Olanda 94
ES - Italia 70
EC - Ecuador 56
LT - Lituania 56
AT - Austria 54
IQ - Iraq 49
CO - Colombia 41
PK - Pakistan 34
PY - Paraguay 32
CZ - Repubblica Ceca 29
IR - Iran 28
KR - Corea 28
MA - Marocco 27
IE - Irlanda 26
VE - Venezuela 26
UZ - Uzbekistan 25
CL - Cile 24
AE - Emirati Arabi Uniti 23
PE - Perù 20
NO - Norvegia 19
SA - Arabia Saudita 19
IL - Israele 17
UY - Uruguay 17
KE - Kenya 16
RO - Romania 16
TN - Tunisia 13
AZ - Azerbaigian 12
CH - Svizzera 11
NP - Nepal 11
AU - Australia 10
DZ - Algeria 10
JO - Giordania 10
LB - Libano 9
TW - Taiwan 9
EG - Egitto 8
EU - Europa 8
NZ - Nuova Zelanda 8
PH - Filippine 8
AL - Albania 7
HN - Honduras 7
SN - Senegal 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
MD - Moldavia 6
PA - Panama 6
BH - Bahrain 5
BO - Bolivia 5
GR - Grecia 5
LV - Lettonia 5
MY - Malesia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
NG - Nigeria 4
NI - Nicaragua 4
AM - Armenia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
OM - Oman 3
SV - El Salvador 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
KG - Kirghizistan 2
MM - Myanmar 2
Totale 54.367
Salva come PNG Salva come JPEG
Città #
Fairfield 3.528
Woodbridge 3.260
Singapore 3.051
Ashburn 2.941
Houston 2.132
Jacksonville 1.842
Ann Arbor 1.682
Chandler 1.529
Seattle 1.418
Hong Kong 1.284
Wilmington 1.259
Beijing 1.230
Santa Clara 1.206
Cambridge 1.191
Munich 546
Izmir 544
Nanjing 493
Dallas 464
Ferrara 447
Los Angeles 446
Princeton 405
New York 372
Boardman 305
San Diego 305
Warsaw 304
Ho Chi Minh City 263
Milan 257
Falkenstein 195
Helsinki 194
São Paulo 193
Shanghai 180
Shenyang 154
Hefei 152
Nanchang 152
Dearborn 146
Hanoi 144
Mexico City 127
London 126
Falls Church 125
Turku 123
San Mateo 113
Tianjin 109
Tokyo 103
Jakarta 96
Jiaxing 96
Brussels 95
Brooklyn 91
Moscow 88
Addison 84
Hebei 84
Changsha 82
Mountain View 81
The Dalles 80
Buffalo 77
Redwood City 77
Chicago 76
Bremen 74
Norwalk 73
Montreal 69
Frankfurt am Main 68
San Francisco 66
Atlanta 64
Bologna 64
Orem 64
Denver 63
Johannesburg 63
Jinan 61
Toronto 61
Rio de Janeiro 60
Washington 60
Stockholm 59
Philadelphia 53
Zhengzhou 53
Auburn Hills 51
Phoenix 47
Kunming 45
Belo Horizonte 44
Boston 44
Guangzhou 44
Poplar 44
Columbus 43
Chennai 38
Montréal 35
Ningbo 35
Brasília 34
Tappahannock 34
Manchester 33
Curitiba 30
Des Moines 29
Ankara 28
Vienna 28
Mcallen 27
Nuremberg 27
Parma 27
St Louis 27
Haiphong 26
Dublin 25
Indiana 25
San Jose 25
Biên Hòa 24
Totale 38.141
Salva come PNG Salva come JPEG
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 352
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 347
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 292
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 262
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 260
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 254
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 244
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 243
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 241
A new selective antagonist of the nociceptin receptor 236
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 235
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 221
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 220
A new ligand for the urotensin II receptor 218
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 213
Designing artificial metalloenzymes exploiting the Spy technology: study of a Cu(II)-Spy construct and perspectives 212
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 212
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 209
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 208
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 207
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 206
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 206
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 206
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 205
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 205
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 205
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 203
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 201
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 200
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 199
Zn(II) and Ni(II) complexes with poly-histidyl peptides derived from a snake venom 197
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 197
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 195
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 195
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 193
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 193
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 193
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 192
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 190
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 190
Physicochemical stability of cabazitaxel and docetaxel solutions 190
Pharmacological characterization of tachykinin tetrabranched derivatives 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 189
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 189
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 188
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 188
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 188
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 187
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 187
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 186
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 185
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 185
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 185
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 183
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 181
Copper-ion interaction with the 106-113 domain of the prion protein: a solution-equilibria study on model peptides 180
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 180
Pharmacological characterization of nociceptin receptor: an in vitro study 179
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 178
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 178
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 177
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 177
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 176
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 176
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 175
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 175
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 174
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 174
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 174
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 173
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 173
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 172
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 172
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 171
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 171
Neuropeptide S receptor ligands: a patent review (2005-2016) 170
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 170
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 169
Design of d-opioid peptide antagonists for emerging drug applications 169
Structure-activity study at positions 3 and 4 of human neuropeptide S. 168
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 168
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 168
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 167
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 167
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 166
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 165
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 165
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 164
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 164
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 164
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 164
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 163
Cardiovascular effects of nociceptin in unanesthetized mice 161
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 161
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 161
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 161
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 160
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 160
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 159
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 159
Totale 19.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 260.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.149
Totale 263.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.175 0 0 0 0 0 558 184 616 162 700 649 306
2021/20224.133 164 406 403 268 268 173 239 266 143 316 321 1.166
2022/20233.859 417 165 123 473 635 534 194 379 543 21 225 150
2023/20241.915 224 248 114 49 110 296 73 176 41 39 62 483
2024/20258.352 213 185 726 258 995 735 244 608 1.350 842 1.163 1.033
2025/202612.935 2.381 982 2.120 3.012 3.186 1.254 0 0 0 0 0 0
Totale 54.982